
Innovative Drug Developer
July 9 news: According to data from Tianyancha, ShanghaiJunshi BiosciencesShanghai Junshi Biosciences Co., Ltd. had 310 insured employees in 2025, a decrease of 50 from the 360 disclosed in 2024, representing a year-on-year decline of 13.89%. The company’s workforce size has contracted somewhat, while its personnel structure continues to be optimized.
(Data sourced from Tianyancha; in case of discrepancies, please refer to the actual information.)
Based on historical changes in the number of insured employees, Shanghai Junshi Biosciences Co., Ltd. had 105 insured employees in 2018, an increase of 56 from the 49 reported in the previous period, representing a year-on-year growth of 114.29%. Both the net increase in headcount and the year-on-year growth rate reached their highest levels in recent years.In 2023, the number of insured employees at Shanghai Junshi Biosciences Co., Ltd. decreased from 468 in the previous period to 384, a reduction of 84, representing a year-on-year decline of 17.95%. This marked the largest year-on-year decrease in the number of insured employees in recent years.
Figure: Trend Chart of the Number of Insured Employees at Shanghai Junshi Biosciences Co., Ltd.
In addition to the number of insured employees, Tianyancha also disclosed the company’s industrial and commercial registration details. Shanghai Junshi Biosciences Co., Ltd. was established on December 27, 2012, with Xiong Jun as its legal representative. The company operates in the biological pharmaceutical manufacturing industry and is classified as a joint-stock limited company (with Hong Kong, Macao, and Taiwan investment and listed status). It is categorized as a large-scale enterprise, with a registered capital of RMB 1,026,689,871 and fully paid-in capital of RMB 1,026,689,871. Its registered address is at 4th Floor, No. 987 Cailun Road, China (Shanghai) Pilot Free Trade Zone. Shareholder information is as follows:
The number of insured employees at Shanghai Junshi Biosciences Co., Ltd. has fluctuated in recent years. From 2016 to 2022, the overall trend was upward, with year-on-year growth rates exceeding 110% in 2018 and 2019, reflecting business expansion and growing manpower needs. However, since 2023, the number of insured employees has declined consecutively, dropping by 17.95% year-on-year in 2023 and by 13.89% in 2025 compared to 2024. This may suggest adjustments in corporate strategy, business contraction, or cost control measures related to human resources. Future developments in its business operations and financial performance warrant close monitoring.
Disclaimer: The market involves risks, and investment should be approached with caution. This article was generated by an AI large language model based on public information and does not represent the views of Sina Finance. All information, data, and charts contained herein are for reference only and do not constitute any form of investment advice or basis for decision-making; please refer to actual announcements for authoritative information. If you have any questions, please contact: biz@staff.sina.com.cn.
Responsible Editor: Xiaolang Express